310 related articles for article (PubMed ID: 27005976)
21. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
22. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
Shaaban SG; Verma V; Choi JI; Shabason J; Sharma S; Glass E; Grover S; Badiyan SN; Simone CB
Clin Lung Cancer; 2018 Sep; 19(5):e685-e692. PubMed ID: 29803576
[TBL] [Abstract][Full Text] [Related]
23. Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.
Bece A; Tin MM; Martin D; Lin R; McLean J; McCaughan B
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):355-62. PubMed ID: 25753747
[TBL] [Abstract][Full Text] [Related]
24. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
Casiraghi M; Maisonneuve P; Brambilla D; Solli P; Galetta D; Petrella F; Piperno G; De Marinis F; Spaggiari L
Eur J Cardiothorac Surg; 2017 Nov; 52(5):975-981. PubMed ID: 28482086
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
Nakas A; von Meyenfeldt E; Lau K; Muller S; Waller D
Eur J Cardiothorac Surg; 2012 May; 41(5):1031-6. PubMed ID: 22219469
[TBL] [Abstract][Full Text] [Related]
27. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
Ishibashi H; Kobayashi M; Takasaki C; Okubo K
Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
[TBL] [Abstract][Full Text] [Related]
28. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
[TBL] [Abstract][Full Text] [Related]
30. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
[TBL] [Abstract][Full Text] [Related]
31. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
[TBL] [Abstract][Full Text] [Related]
32. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
[TBL] [Abstract][Full Text] [Related]
33. Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
Cao C; Krog Andvik SK; Yan TD; Kennedy C; Bannon PG; McCaughan BC
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):754-7. PubMed ID: 21303872
[TBL] [Abstract][Full Text] [Related]
34. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.
Lauk O; Hoda MA; de Perrot M; Friess M; Klikovits T; Klepetko W; Keshavjee S; Weder W; Opitz I
Ann Thorac Surg; 2014 Nov; 98(5):1748-54. PubMed ID: 25110339
[TBL] [Abstract][Full Text] [Related]
35. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Friedberg JS; Simone CB
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):758-766.e1. PubMed ID: 30454981
[TBL] [Abstract][Full Text] [Related]
36. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
[TBL] [Abstract][Full Text] [Related]
37. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.
Linton A; Pavlakis N; O'Connell R; Soeberg M; Kao S; Clarke S; Vardy J; van Zandwijk N
Br J Cancer; 2014 Oct; 111(9):1860-9. PubMed ID: 25188323
[TBL] [Abstract][Full Text] [Related]
39. Pleural mesothelioma: is the surgeon still there?
Opitz I; Weder W
Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
[TBL] [Abstract][Full Text] [Related]
40. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
Doyle LA; Showalter TN; Werner-Wasik M; Weksler B; Xiao Y; Yu Y; Macrone A; Liu H; Harrison A
Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
